The invention discloses hyacinth bean-gorgon euryale seed dispersible tablets which comprise the following components: 200-400g of rhizoma dioscoreae, 100-200g of hyacinth beans, 200-280g of gorgon euryale seeds, 40-60g of microcrystalline cellulose, 0.1-0.3g of calcium gluconate, 0.05-0.15g of magnesium carbonate, 40-60g of soybean protein powder, 0.12-0.32g of a coriolus versicolor extract, 0.38-0.78g of calcium carbonate, 0.011-0.022g of ferrous fumarate, 1-2g of vitamin C, 1-2mug of vitamin D, 100-170g of mannitol, 10-15g of sucralose, 10-50g of aerosil, 3-5g of carboxymethylcellulose, 55-80g of sodium carboxymethyl starch, 4-6g of magnesium stearate and a proper amount of alpha-amylase and purified water. The hyacinth bean-gorgon euryale seed dispersible tablets disclosed by the invention have the functions of tonifying spleen and kidney, removing damp turbidity, stopping leukorrhagia, increasing bone mineral density, improving alimentary anemia and enhancing immunity, are suitable for leukorrheal diseases and are used for assisting the recovery.